By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Proteo Biotech AG 

Am Kiel-Kanal 44

Kiel    D-24106  Germany
Phone: 49-431-8888-462 Fax: 49-431-8888-463



Company News
Proteo Inc. (PTEO.OB)/Proteo Biotech AG (PTEO.OB): Elafin Combined With Cyclosporine Promises To Overcome Limitations Of Cyclosporine For Preventing Irreversible Damage To Transplanted Organs 3/12/2015 10:27:35 AM
Proteo Biotech AG (PTEO.OB) Expands Management Board 12/5/2014 9:17:42 AM
Proteo Inc. (PTEO.OB)/Proteo Biotech AG (PTEO.OB): Final Analysis Of The Phase II Clinical Study On Elafin In Coronary Artery Bypass Surgery Completed 11/21/2014 9:26:36 AM
Proteo Inc. (PTEO.OB) / Proteo Biotech AG (PTEO.OB): Patient Recruitment and Treatment in Elafin CABG Phase II Clinical Trial Completed 11/8/2013 8:09:01 AM
Proteo Inc. (PTEO.OB) /Proteo Biotech AG (PTEO.OB): FDA Grants Orphan Drug Designation to Elafin for Prevention of Inflammatory Complications of Transthoracic Esophagectomy 3/21/2013 11:27:19 AM
Proteo Inc. (PTEO.OB)/ Proteo Biotech AG (PTEO.OB): Proteo's Elafin Will Be Tested at the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) 6/18/2010 6:22:05 AM
Proteo Inc. (PTEO.OB)/Proteo Biotech AG (PTEO.OB): Successful Completion of Patient Recruitment for the Phase II Clinical Trial on Elafin in Patients with Esophagus Cancer 4/23/2010 10:03:28 AM
Proteo Inc. (PTEO.OB)/Proteo Biotech AG (PTEO.OB): European Medicines Agency European Medicines Evaluation Agency Recommends Orphan Drug Status for Elafin in the Treatment of Esophagus Carcinoma 11/16/2009 10:16:17 AM
Proteo Inc. (PTEO.OB)/Proteo Biotech AG (PTEO.OB) - Minapharm/Rhein Minapharm Biogenetics SAE: Approval for a Phase II Clinical Trial with Elafin in Kidney Transplantation 12/10/2008 10:04:58 AM
Proteo Inc. (PTEO.OB)/Proteo Biotech AG (PTEO.OB): Start of the Phase II Clinical Trial With Elafin 11/17/2008 11:36:42 AM